Senomyx, Inc. discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents. It sells various flavor ingredients directly to flavor companies. The company has collaboration agreements with Ajinomoto Co., Inc.; Firmenich SA; and PepsiCo, Inc. Senomyx, Inc. was founded in 1998 and is headquartered in San Diego, California.
Industry, Sector and Symbol
Industry Commercial physical research
Sub-IndustryN/A
SectorConsumer Staples
Phone858-646-8300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$29.32 million
Profitability
Miscellaneous
Employees56
OptionableOptionable
Senomyx (NASDAQ:SNMX) Frequently Asked Questions
What is Senomyx's stock symbol?
Senomyx trades on the NASDAQ under the ticker symbol "SNMX."
How were Senomyx's earnings last quarter?
Senomyx Inc. (NASDAQ:SNMX) released its earnings results on Thursday, August, 2nd. The specialty chemicals company reported ($0.08) EPS for the quarter, beating analysts' consensus estimates of ($0.09) by $0.01. The specialty chemicals company had revenue of $3.29 million for the quarter. Senomyx had a negative return on equity of 15.80% and a negative net margin of 9.11%. View Senomyx's Earnings History.
Has Senomyx been receiving favorable news coverage?
News coverage about SNMX stock has been trending very positive recently, according to InfoTrie. The research group ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Senomyx earned a news sentiment score of 3.2 on InfoTrie's scale. They also assigned press coverage about the specialty chemicals company a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.
Who are some of Senomyx's key competitors?
Some companies that are related to Senomyx include Sorrento Therapeutics (SRNE), Pieris Pharmaceuticals (PIRS), Luna Innovations (LUNA), Anavex Life Sciences (AVXL), Dyadic International (DYAI), BIOQUAL (BIOQ), HedgePath Pharmaceuticals (HPPI), Vitality Biopharma (VBIO), Cleveland BioLabs (CBLI), Bioanalytical Systems (BASI), US Stem Cell (USRM), Geovax Labs (GOVX), Protalex (PRTX), ALGAE TEC LTD/S (ALGXY) and Tenax Therapeutics (TENX).
Who are Senomyx's key executives?
Senomyx's management team includes the folowing people:
- Mr. John W. Poyhonen, Pres, CEO & Director (Age 58)
- Mr. David C. Humphrey, VP & CFO (Age 49)
- Ms. Catherine C. Lee, Sr. VP, Gen. Counsel & Corp. Sec. (Age 44)
- Ms. Sharon Wicker, Sr. VP & Chief Commercial Devel. Officer (Age 62)
- Ms. Susan Firestone Melody, VP of HR
How do I buy shares of Senomyx?
Shares of SNMX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How big of a company is Senomyx?
Senomyx has a market capitalization of $0.00 and generates $29.32 million in revenue each year. The specialty chemicals company earns $-1,260,000.00 in net income (profit) each year or ($0.03) on an earnings per share basis. Senomyx employs 56 workers across the globe.
What is Senomyx's official website?
How can I contact Senomyx?
Senomyx's mailing address is 4767 NEXUS CENTRE DRIVE, SAN DIEGO CA, 92121. The specialty chemicals company can be reached via phone at 858-646-8300 or via email at [email protected]
MarketBeat Community Rating for Senomyx (NASDAQ SNMX)
MarketBeat's community ratings are surveys of what our community members think about Senomyx and other stocks. Vote "Outperform" if you believe SNMX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SNMX will underperform the S&P 500 over the long term. You may vote once every thirty days.
